India: The annual revenue of the global vaccine industry is expected to be $35 billion for 2014. With Compounded Annual...
New Delhi: The Indian Council of Agricultural Research signed a memorandum of understanding (MoU) with Sanvita Biotechno...
Singapore: At the AIDS 2014 Conference in Melbourne, Australia, scientists declared that they had identified a biomarker...
‎Singapore: China's vaccine company, Sinovac Biotech has appointed Ms Nan Wang, who is presently the VP of Sinovac...
Singapore: Chinese scientists have discovered a new vaccine for Japanese encephalitis that kills millions every year acr...
Singapore: Sinovac Biotech, a leading provider of vaccines in China, reported that its hepatitis vaccines sales in priva...
Bangalore: Sanofi Pasteur, the vaccines division of Sanofi, will provide 1.7 billion doses of oral polio vaccine (OPV) t...
Singapore: Clinical-stage Dutch biotechnology company, Mucosis has entered into a long-term collaboration and license ag...
Singapore: South Korea-headquartered International Vaccine Institute (IVI) has appointed Professor Fred Binka, Dr Josep...
Bangalore: Bharat Biotech and The University of Maryland Center for Vaccine Development have received a $4 million strat...
Singapore: Saudi health officials declared that they had finally discovered new antibodies to combat the MERS virus. The...
Singapore: Tokyo-headquartered Eisai has signed a global agreement with Brazil's Fundação Oswaldo Cruz for collabo...
Singapore: Marking the start of the World Immunization Week, the Hilleman Laboratories, an equal joint-venture partnersh...
Singapore: Influenza vaccine (gH1-Qbeta) developed by Singapore's Agency for Science, Technology and Research (A*STAR) a...
Hyderabad: Dr Vijay Kumar Datla, chairman and managing director of Biological E, will be given FABA Special Award 2013 ...
During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two mo...
Singapore: Researchers at the Burnet Institute have solved a hepatitis C vaccine mystery which, once developed, could b...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...